Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lichtenberg

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Health Care Finance and Economics|February 17, 2005
The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001Frank R Lichtenberg
Journal of General Internal Medicine|September 17, 2009
Do new drugs save lives?Frank R Lichtenberg
Pharmacoeconomics|February 3, 2007
The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003Frank R Lichtenberg
Advances in Health Economics and Health Services Research|June 26, 2010
The effect of drug vintage on survival: micro evidence from Puerto Rico's Medicaid programFrank R Lichtenberg
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 11, 2002
New drugs and lower costsFrank R Lichtenberg
Health Affairs (Project Hope)|September 18, 2001
Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPSF R Lichtenberg
Forum for Health Economics & Policy|August 18, 2019
The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use FilesFrank R Lichtenberg
Health Affairs (Project Hope)|August 9, 2011
Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-beingFrank R Lichtenberg
Health Economics|July 18, 2008
Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003Frank R Lichtenberg
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series dataFrank R Lichtenberg
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Health Care Finance and Economics|February 17, 2005
The impact of new drug launches on longevity: evidence from longitudinal, disease-level data from 52 countries, 1982-2001Frank R Lichtenberg
Journal of General Internal Medicine|September 17, 2009
Do new drugs save lives?Frank R Lichtenberg
Pharmacoeconomics|February 3, 2007
The effect of using newer drugs on admissions of elderly Americans to hospitals and nursing homes: state-level evidence from 1997 to 2003Frank R Lichtenberg
Advances in Health Economics and Health Services Research|June 26, 2010
The effect of drug vintage on survival: micro evidence from Puerto Rico's Medicaid programFrank R Lichtenberg
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 11, 2002
New drugs and lower costsFrank R Lichtenberg
Health Affairs (Project Hope)|September 18, 2001
Are the benefits of newer drugs worth their cost? Evidence from the 1996 MEPSF R Lichtenberg
Forum for Health Economics & Policy|August 18, 2019
The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use FilesFrank R Lichtenberg
Health Affairs (Project Hope)|August 9, 2011
Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-beingFrank R Lichtenberg
Health Economics|July 18, 2008
Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003Frank R Lichtenberg
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series dataFrank R Lichtenberg
Pageof 10